8BI.F Health and Happiness (H&H) International Holdings Limited
- Market cap
- EUR 1.83B
- P/E
- 20.3x
- P/B
- 2.09x
- ROE
- 3.3%
- Dividend yield
- 3.94%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is 8BI.F undervalued?
Graham number8BI.F trades 37.4% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Health and Happiness (H&H) International Holdings Limited fundamental analysis
No fundamental analysis for Health and Happiness (H&H) International Holdings Limited yet.
Health and Happiness (H&H) International Holdings Limited stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Health and Happiness (H&H) International Holdings Limited
Health and Happiness (H&H) International Holdings Limited, an investment holding company, manufactures and sells pediatric nutrition, baby care, adult nutrition and care, and pet nutrition and care products in Mainland China, Australia, New Zealand, North America, and internationally. The company offers milk formulas for infants, children, and expectant and nursing mothers; probiotic and nutrition supplements in the form of sachets, capsules, gummies, and tablets for infants…
Full company profileHealth and Happiness (H&H) International Holdings Limited financial statements
Health and Happiness (H&H) International Holdings Limited annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 6.51B | 8.10B | 10.1B | 10.9B | 11.2B | 11.5B | 12.8B | 13.9B | 13.1B | 14.4B |
| Gross Profit | 4.06B | 5.27B | 6.74B | 7.23B | 7.19B | 7.25B | 7.70B | 8.29B | 7.92B | 8.96B |
| Operating Income | 1.76B | 2.09B | 2.45B | 2.16B | 1.95B | 1.62B | 1.77B | 1.94B | 1.40B | 1.71B |
| EBITDA | - | 2.07B | 2.12B | 2.19B | 2.13B | 1.42B | 1.87B | 2.04B | 1.37B | 1.56B |
| Net Income | 954M | 933M | 843M | 1.01B | 1.14B | 508M | 612M | 582M | -53.7M | 196M |
| EPS | - | 1.46 | 1.32 | 1.56 | 1.76 | 0.79 | 0.95 | 0.90 | -0.08 | 0.30 |
| Balance Sheet | ||||||||||
| Total Assets | 14.2B | 14.1B | 14.9B | 15.9B | 17.2B | 20.3B | 21.0B | 20.0B | 18.8B | 19.4B |
| Total Liabilities | 11.0B | 9.92B | 10.0B | 10.3B | 11.0B | 14.4B | 14.8B | 13.7B | 13.0B | 13.4B |
| Shareholders' Equity | 3.16B | 4.21B | 4.85B | 5.59B | 6.20B | 5.89B | 6.14B | 6.30B | 5.81B | 5.99B |
| Cash & Short-term Investments | 1.51B | 2.09B | 1.91B | 2.22B | 1.83B | 2.40B | 2.30B | 1.36B | 1.60B | 1.67B |
| Cash Flow | ||||||||||
| Operating Cash Flow | 1.54B | 1.95B | 1.70B | 1.44B | 1.53B | 1.89B | 1.47B | 1.10B | 1.35B | 1.54B |
| Capital Expenditure | 88.4M | 73.6M | 63.2M | 105M | 81.3M | 53.3M | 102M | 91.0M | 97.3M | 94.4M |
| Free Cash Flow | - | 1.37B | 1.43B | 1.31B | 1.43B | 1.78B | 1.37B | 1.01B | 1.25B | 1.44B |
| Ratios | ||||||||||
| ROE | 30.2% | 22.1% | 17.4% | 18.0% | 18.3% | 8.6% | 10.0% | 9.2% | -0.9% | 3.3% |
| ROA | 6.7% | 6.6% | 5.7% | 6.3% | 6.6% | 2.5% | 2.9% | 2.9% | -0.3% | 1.0% |
| Net Profit Margin | 14.7% | 11.5% | 8.3% | 9.2% | 10.2% | 4.4% | 4.8% | 4.2% | -0.4% | 1.4% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Health and Happiness (H&H) International Holdings Limited dividends
- Dividend yield
- 3.94%
- Forward dividend
- 0.11 EUR
- Payout ratio
- 72.1%
- Ex-dividend date
- Sep 10, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 141M | 0.22 | 72.1% |
| 2024 | CNY 282M | 0.44 | - |
| 2023 | CNY 475M | 0.74 | 81.6% |
| 2022 | CNY 234M | 0.36 | 38.2% |
| 2021 | CNY 408M | 0.63 | 80.1% |
| 2020 | CNY 862M | 1.34 | 75.8% |
| 2019 | EUR 272M | 0.42 | 27.0% |
| 2018 | EUR 272M | 0.42 | 32.2% |
| 2017 | EUR 272M | 0.43 | 29.1% |
| 2016 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Health and Happiness (H&H) International Holdings Limited
- Insiders 67.64%
- Institutions 13.34%
- Public & others 19.02%
- Shares outstanding 646M
- Free float 209M
Health and Happiness (H&H) International Holdings Limited company profile
- Company name
- Health and Happiness (H&H) International Holdings Limited
- Ticker
- 8BI.F
- ISIN
- KYG4387E1070
- Exchange
- Frankfurt Exchange
- Sector
- Consumer Defensive
- Industry
- Food Products
- Employees
- 2,758
- Fiscal year end
- December
- Address
- One Island East, Quarry Bay, Hong Kong
- Website
- hh.global
About Health and Happiness (H&H) International Holdings Limited
Health and Happiness (H&H) International Holdings Limited, an investment holding company, manufactures and sells pediatric nutrition, baby care, adult nutrition and care, and pet nutrition and care products in Mainland China, Australia, New Zealand, North America, and internationally. The company offers milk formulas for infants, children, and expectant and nursing mothers; probiotic and nutrition supplements in the form of sachets, capsules, gummies, and tablets for infants, children, and expectant mothers; and vitamins, herbal and mineral supplements, and skin care and sports nutrition products for adults; dried baby food and baby care products; and complete pet food products and multicondition pet supplements. In addition, it is involved in the research, development, manufacture, sale, and processing of meat, fruit, vegetable powder, candy, special nutritional food, and nutritional products; marketing and distribution of organic baby food; wholesale, retail, import, and export of nutritional food and personal care products for infants; and provision of packaging services. Further, the company engages in the trading and sale of vitamins, health supplements, and skin care and sports nutrition products for adults; and pet food, and nutritional supplements for pets, as well as the online sale and provision of software and information technology. It provides its products under the Healthy Times, Farmland, Swisse, Aurelia, Zesty Paws, Solid Gold, Dodie, and Good Goût brand names. The company was formerly known as Biostime International Holdings Limited and changed its name to Health and Happiness (H&H) International Holdings Limited in June 2017. The company was founded in 1999 and is headquartered in Quarry Bay, Hong Kong. Health and Happiness (H&H) International Holdings Limited is a subsidiary of Coliving Holdings Limited.
Health and Happiness (H&H) International Holdings Limited management
10- Mr. Fei LuoExecutive Chairman of the Board · born 1964
- Mr. Yidong WangCFO & Executive Director · born 1974
- Mr. Akash BediCEO & CEO of Europe, North America, Middle East and India · born 1985
- Dr. Johannes Jacobus CapponChief Technology Officer · born 1966
- Ms. Pascale LabordeChief Growth & Sustainability Officer and Director of Global Marketing and Communications · born 1980
- Mr. Qizhang ZhangChief People Officer · born 1984
- Ms. Fengting LiChief Executive Officer for China · born 1986
- Mr. Nicholas Russell Lamande MannChief Executive Officer for Asia, Australia & New Zealand · born 1975
- Mr. Christian SimChief Supply Chain Officer · born 1974
- Ms. Wenyun YangSenior Director of the Listing Affairs & Risk Management Department and Company Secretary · born 1984